Neuphoria Therapeutics Inc Revenue

Biotechnology Research • Burlington, Massachusetts, United States • 21-50 Employees

Neuphoria Therapeutics Inc revenue & valuation

Annual revenue	$60,000,000
Revenue per employee	$1,715,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$192,000,000
Total funding	$70,000,000

Key Contacts at Neuphoria Therapeutics Inc

Miles Davies

Non Executive Director, Audit Committee Member

Michael Odontiadis

Director Clinical Operations

Dharam Paul

Senior Director Of Discovery And Development Sciences

Rachel Kimber

Executive Assistant To Ceo & Managing Director

Company overview

Headquarters	100 Summit Dr, Burlington, Massachusetts 01803, US
Phone number	+161881507400
Websites	neuphoriatx.com bionomics.com.au
NAICS	541714
Keywords	Anxiety, Ptsd, Biopharmaceutical, Neuropsychiatry, Central Nervous System Disorders, Social Anxiety
Employees	21-50
Socials

Neuphoria Therapeutics Inc Email Formats

Neuphoria Therapeutics Inc uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@bionomics.com.au), used 77.8% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@bionomics.com.au	77.8%
{first name}{last name}	johndoe@bionomics.com.au	22.2%

About Neuphoria Therapeutics Inc

At Neuphoria Therapeutics, we are dedicated to pioneering breakthrough therapies that address the complex needs of individuals affected by neuropsychiatric disorders. By focusing on novel approaches and advancing scientific understanding, we aim to deliver medicines that offer lasting relief and hope for a brighter, healthier future. To learn more about the company, pipeline and collaboration opportunities, visit us at www.neuphoriatx.com

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Director

C-Suite

Employees by Department

Neuphoria Therapeutics Inc has 11 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Neuphoria Therapeutics Inc's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-07-01	14	$70,000,000

Funding Insights

$70,000,000

Total funding amount

$70,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Neuphoria Therapeutics Inc is located in Burlington, Massachusetts, US.

You can reach Neuphoria Therapeutics Inc at +161881507400.

Neuphoria Therapeutics Inc generates an estimated annual revenue of $60,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Neuphoria Therapeutics Inc has an estimated valuation of $192,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Neuphoria Therapeutics Inc has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Neuphoria Therapeutics Inc has raised a total of $70,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.